FM
INSIDER · ANTX · AN2 Therapeutics, Inc. · DIRECTOR
FitzPatrick Margaret M
Every open-market transaction filed under this name, Sep 1 to Sep 1.
Filings
1
1 buy · 0 sells
Bought
$12K
open market, at cost
Sold
—
includes scheduled sales
Buys since
+7.6%
avg move from buy price, 1 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 1 | ANTX | AN2 Therapeutics, Inc. | Director | Buy | 2,098 | $5.53 | $12K | +7.6% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.